Mizuho raises Haemonetics price target to $90

0 min read | Published on 16 Jul 2026, 02:38 AM |Updated on 16 Jul 2026, 02:38 AM

Reviewed by

Radhika SScanX News Team

Key Highlights

Mizuho analyst Anthony Petrone maintained an Outperform rating on Haemonetics and raised the price target from $85 to $90.

*this image is generated using AI for illustrative purposes only.

Mizuho analyst Anthony Petrone has maintained an Outperform rating on Haemonetics while raising the price target to $90. The previous target was $85. The rating and target adjustment were issued by the firm covering the stock listed on the NYSE under the ticker HAE.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove Mizuho to raise the price target for Haemonetics?

How might Haemonetics' recent performance influence its competitive position in the medical device market?

What are the potential risks or challenges Haemonetics could face in achieving the new $90 price target?

Haemonetics to announce Q1 FY27 results on August 6, 2026

1 min read | Published on 09 Jul 2026, 04:12 AM |Updated on 09 Jul 2026, 04:12 AM

Reviewed by

Suketu GScanX News Team

Add as a preferred
source on Google

Key Highlights

Haemonetics Corporation will release its Q1 FY27 financial results on August 6, 2026, followed by an investor conference call. A live webcast and a one-year replay will be available for access.

*this image is generated using AI for illustrative purposes only.

Haemonetics Corporation announced it will publish its first quarter fiscal year 2027 financial results on August 6, 2026. The company will hold a conference call with investors and analysts to discuss the results and address questions at 8:00 am ET on the same day. The financial results will be released at 6:00 am ET.

Conference Call Details

Investors can access the conference call via teleconference after completing registration. Participants will receive a dial-in number and a personalized PIN. Joining 10 minutes prior to the event start is recommended.

A live webcast of the call will be available on Haemonetics' investor relations website. The webcast link is provided for access.

Replay Availability

A replay of the conference call and webcast will be accessible for one year starting at 11:00 am ET on August 6, 2026. The replay can be accessed using the conference call webcast link provided in the release.

Key Dates and Times

Event	Date	Time (ET)
Financial Results Release	August 6, 2026	6:00 am
Conference Call	August 6, 2026	8:00 am
Replay Availability	August 6, 2026	11:00 am

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What strategic initiatives does Haemonetics plan to prioritize in FY 2027?

How might market conditions impact Haemonetics' financial performance in the upcoming quarter?

What key metrics or trends should investors watch for during the conference call?

Mizuho raises Haemonetics price target to $90

Haemonetics to announce Q1 FY27 results on August 6, 2026

Conference Call Details

Replay Availability

Key Dates and Times

More News on Haemonetics Corp

Earnings

Corporate Actions

Stocks

Get More Market Insights with

Trending News

Find the Right Stock
Easily on ScanX

Today's Top Gainers

Today's Top Losers

Global Indices

Mizuho raises Haemonetics price target to $90

Haemonetics to announce Q1 FY27 results on August 6, 2026

Conference Call Details

Replay Availability

Key Dates and Times

More News on Haemonetics Corp

Earnings

Corporate Actions

Stocks

Get More Market Insights with

Trending News

Find the Right StockEasily on ScanX

Today's Top Gainers

Today's Top Losers

Global Indices

Find the Right Stock
Easily on ScanX